Literature DB >> 16337696

Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function.

Camin Dean1, Thomas Dresbach.   

Abstract

Cell adhesion represents the most direct way of coordinating synaptic connectivity in the brain. Recent evidence highlights the importance of a trans-synaptic interaction between postsynaptic neuroligins and presynaptic neurexins. These transmembrane molecules bind each other extracellularly to promote adhesion between dendrites and axons. This signals the recruitment of presynaptic and postsynaptic molecules to form a functional synapse. Remarkably, neuroligins alone can induce the formation of fully functional presynaptic terminals in contacting axons. Conversely, neurexins alone can induce postsynaptic differentiation and clustering of receptors in dendrites. Therefore, the neuroligin-neurexin interaction has the unique ability to act as a bi-directional trigger of synapse formation. Here, we review several recent studies that offer clues as to how these proteins form synapses and how they might function in the brain to establish and modify neuronal network properties and cognition.

Mesh:

Substances:

Year:  2005        PMID: 16337696     DOI: 10.1016/j.tins.2005.11.003

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  137 in total

Review 1.  Looking for sexual selection in the female brain.

Authors:  Molly E Cummings
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-08-19       Impact factor: 6.237

2.  The postsynaptic adenomatous polyposis coli (APC) multiprotein complex is required for localizing neuroligin and neurexin to neuronal nicotinic synapses in vivo.

Authors:  Madelaine M Rosenberg; Fang Yang; Jesse L Mohn; Elizabeth K Storer; Michele H Jacob
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

3.  Crystal structure of the second LNS/LG domain from neurexin 1alpha: Ca2+ binding and the effects of alternative splicing.

Authors:  Lauren R Sheckler; Lisa Henry; Shuzo Sugita; Thomas C Südhof; Gabby Rudenko
Journal:  J Biol Chem       Date:  2006-06-13       Impact factor: 5.157

Review 4.  Molecular genetics of addiction vulnerability.

Authors:  George R Uhl
Journal:  NeuroRx       Date:  2006-07

Review 5.  Neurexin-neuroligin signaling in synapse development.

Authors:  Ann Marie Craig; Yunhee Kang
Journal:  Curr Opin Neurobiol       Date:  2007-02-01       Impact factor: 6.627

6.  Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin.

Authors:  Kensuke Futai; Myung Jong Kim; Tsutomu Hashikawa; Peter Scheiffele; Morgan Sheng; Yasunori Hayashi
Journal:  Nat Neurosci       Date:  2007-01-21       Impact factor: 24.884

7.  Crystal structures of beta-neurexin 1 and beta-neurexin 2 ectodomains and dynamics of splice insertion sequence 4.

Authors:  Jesko Koehnke; Xiangshu Jin; Nikola Trbovic; Phinikoula S Katsamba; Julia Brasch; Goran Ahlsen; Peter Scheiffele; Barry Honig; Arthur G Palmer; Lawrence Shapiro
Journal:  Structure       Date:  2008-03       Impact factor: 5.006

Review 8.  Control of alternative pre-mRNA splicing by Ca(++) signals.

Authors:  Jiuyong Xie
Journal:  Biochim Biophys Acta       Date:  2008-01-17

Review 9.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls.

Authors:  Vassilis N Panagopoulos; Timothy J Trull; Anne L Glowinski; Michael T Lynskey; Andrew C Heath; Arpana Agrawal; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Pamela A F Madden; Elizabeth Moore; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery; Elliot C Nelson
Journal:  Drug Alcohol Depend       Date:  2012-12-12       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.